Meeder Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.6K | Buy |
|
|||||
|
2025
Q2 | $4.18K | Buy |
|
|||||
|
2025
Q1 | $3.39K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $51.7K | Buy |
|
|||||
|
2024
Q2 | $5.93K | Sell |
|
|||||
|
2024
Q1 | $6.81K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $414 | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $3K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $4K | Sell |
|
|||||
|
2021
Q2 | $6K | Hold |
|
|||||
|
2021
Q1 | $5K | Sell |
|
|||||
|
2020
Q4 | $8K | Sell |
|
|||||
|
2020
Q3 | $11K | Sell |
|
|||||
|
2020
Q2 | $2.03M | Buy |
|
|||||
|
2020
Q1 | $208K | Buy |
|
|||||
|
2019
Q4 | $189K | Buy |
|
|||||
|
2019
Q3 | $27K | Buy |
|
|||||
|
2019
Q2 | $20K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $18K | Sell |
|
|||||
|
2018
Q3 | $48K | Hold |
|
|||||
|
2018
Q2 | $46.2K | Sell |
|
|||||
|
2018
Q1 | $43K | Hold |
|
|||||
|
2017
Q4 | $47K | Sell |
|
|||||
|
2017
Q3 | $78K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $110K | Sell |
|
|||||
|
2016
Q2 | $140K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $112K | Buy |
|
|||||
|
2015
Q3 | $73K | Buy |
|